Vivian van den Boogaart

Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer

Anne‐Marie C. Dingemans, Vivian van den Boogaart, Bettine A.H. Vosse et al. · Molecular Cancer · 2010 · 128 citations · Full text

Monitoring Response to Antiangiogenic Therapy in Non–Small Cell Lung Cancer Using Imaging Markers Derived from PET and Dynamic Contrast-Enhanced MRI

Adrianus J. de Langen, Vivian van den Boogaart, Mark Lubberink et al. · Journal of Nuclear Medicine · 2010 · 100 citations · Full text

First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging

Anne‐Marie C. Dingemans, Adrianus J. de Langen, Vivian van den Boogaart et al. · Annals of Oncology · 2010 · 71 citations · Full text

Medicine, First-line Erlotinib, Molecular Imaging +10

Galectin Expression Profiling Identifies Galectin-1 and Galectin-9Δ5 as Prognostic Factors in Stage I/II Non-Small Cell Lung Cancer

Iris A. Schulkens, Roy Heusschen, Vivian van den Boogaart et al. · PLoS ONE · 2014 · 27 citations · Full text

Prognostic Factors, Tumor Biology, Prognostic Biomarkers +15